Impact of Systemic Diseases on Olfactory Function in COVID-19 Infected Patients
Ayat A Awwad,Moustafa M Rabie,Eman A Awad,Fatma M Kotb,Hend M Maghraby,Rmadan H Eldamarawy,Ahmed H Elsheshiny,Osama MM Abd Elhay,Yahia MA Dawood,Mostafa IEI Balat,Ahmed IM Hasan,Said SMM El Sayed,Albayoumi AB Fouda,Ahmad MF Alkot
DOI: https://doi.org/10.2147/IJGM.S355974
IF: 2.145
2022-06-18
International Journal of General Medicine
Abstract:Ayat A Awwad, 1 Osama MM Abd Elhay, 2 Moustafa M Rabie, 3 Eman A Awad, 4 Fatma M Kotb, 4 Hend M Maghraby, 4 Rmadan H Eldamarawy, 4 Yahia MA Dawood, 1 Mostafa IEI Balat, 1 Ahmed IM Hasan, 5 Ahmed H Elsheshiny, 6 Said SMM El Sayed, 2 Albayoumi AB Fouda, 2 Ahmad MF Alkot 2 1 Otorhinolaryngology department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; 2 Medical Physiology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; 3 Public Health and Community Medicine Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; 4 Internal medicine department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; 5 Pediatric Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt; 6 Neurology department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt Correspondence: Ayat A Awwad, Otorhinolaryngology department, Faculty of Medicine, Al-Azhar University, Al Zhraa University Hhospital, Alabasia, Cairo, 11517, Egypt, Email ; Osama MM Abd Elhay, Medical Physiology Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt, Email ; Background: COVID-19 (SARS-CoV-2/2019-nCoV) is now a major public health threat to the world. Olfactory dysfunctions (ODs) are considered potential indicating symptoms and early case identification triaging for coronavirus disease 2019 (COVID-19). The most common reported comorbidities are diabetes mellitus, chronic lung disease, and cardiovascular disease. The objective of this study was to evaluate prevalence of different types of smell disorders in patients with laboratory-confirmed COVID-19 infection and impact of involved systemic diseases. Methodology: A cross-sectional retrospective study has been done for patients with laboratory-confirmed COVID-19 infection (mild-to-moderate). The data collected from patient's files and developed online electronic questionnaire (WhatsApp) based on the patients most common and recurrent reported data including: a) symptoms of olfactory dysfunction and associated covid19 symptoms fever and headache, cough, sore throat, pneumonia, nausea, vomiting and diarrhea, arthralgia and myalgia and taste dysfunction. b) Associated systemic diseases including: diabetes, hypertension, asthma, chronic renal disease, chorionic liver disease and hypothyroidism. Results: Of 308 patients confirmed with Covid-19 infection, (72.4%) developed OD distributed as follows; complete anosmia (57.8%), troposmia (8.4%), hyposmia (2.9%), partial anosmia (2.6%) and euosmia (0.6%). Significantly increased prevalence of diabetes, hypertension asthma in the group with olfactory dysfunction (p < 0.001), chronic liver disease (p = 0.005), and hypothyroidism (p = 0.03). Conclusion: The development of ODs after Covid-19 infection was associated with mild disease form and lower hospitalization. In addition, it showed significant relationship with preexisting systemic diseases. Anosmia is the common modality of ODs. Keywords: COVID-19, anosmia, olfactory dysfunction World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) to be pandemic after it quickly spread all over the world. 1 The involved cause is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 2 Human-to-human transmission is extremely rapid. 3 Coronavirus is contagious with an incubation period ranging from 2 to 14 days. Through this period, patients can transmit infection even if asymptomatic. 4 Asia reported that the most prevalent symptoms as: fever, myalgia, arthralgia cough, dyspnea, headache, diarrhea, rhinorrhea, and sore throat. 5 Also, respiratory complications as pneumonia, lung fibrosis, and even death have been reported. 6 Later, atypical presentation of the disease is widely observed including olfactory and gustatory malfunction but without rhinorrhea or nasal obstruction which are usually associated to other respiratory viral infections. 7 WHO considers smell disorders as key symptoms of COVID-19. 8 The American Academy of Otolaryngology–Head and Neck Surgery Foundation, 2020 9 together with Ear, Nose, and Throat Society of the United Kingdom (ENTUK) recommended self-isolation for patients presenting with these clinical features. Many countries reported the association smell disorder and taste with COVID-19 10–12 , but evidence remains controversial. In addition, none of them was concerned the incidence of different types of dysfunction. COVID-19 virus appears to be more severe in severe older people and people with systemic conditions (such as di -Abstract Truncated-
medicine, general & internal